Volume 3, Issue 1 And 2 (9-1996)                   RJMS 1996, 3(1 And 2): 178-178 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Balali M. RECENT ADVANCES IN TREATMENT OF OP PESTICIDE POISONING. RJMS 1996; 3 (1 and 2) :178-178
URL: http://rjms.iums.ac.ir/article-1-1839-en.html
Abstract:   (15891 Views)

Organophosphate (OP) compounds have largely been used as pesticides and also as nerve agents in Chemical Wars. OP pesticides have frequently been imported and freely available to the public without usage control. Therefore, OP poisoning, mainly intentional type, is very common and accounts for 21.8% (250 patients) of the total admission to the hospital between 21 March 1994 and 20 March 1995.

OP compounds induce accumulation of acetyl choline by inhibition of acetyl cholinestrase leading to the stimulation of muscarinic and nicotinic receptors. Muscarinic effects are counteracted successfully by atropine sulfate, but the therapeutic effects of oximes on nicotinic receptors and cholinestrase reactivation have not been observed in clinical practice. Clinical obervations of the author and a report from Sri Lanka (Lancet 339,1992), indicates no therapeutic effects of oximes in OP poisoning. Case notes of 317 Treatment Centres between 21 March 1993 and 20 March 1995 were studied.

There were significant positive correlations between the oxime doses and either hospitalization days (r=0.625, p<0.001) or mortality rate (= 0.718, p<0.01).

It seems that oximes had no therapeutic effects on OP pesticide poisoning. However, a prospective investigation is currently undertaken to confirm this hypothesis.

Full-Text [PDF 994 kb]   (2061 Downloads)    
Type of Study: Research | Subject: Biochemistry

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb